Timing of antiretroviral drugs during tuberculosis therapy
Garcia-Vidal, C.; Salvado, M.; Salavert, M.
New England Journal of Medicine 362(22): 2137-2138; Author Reply 2138-2139
2010
ISSN/ISBN: 0028-4793 PMID: 20527080 Document Number: 638738
Document emailed within 1 workday
Related Documents
Kadhiravan, T. 2010: Timing of antiretroviral drugs during tuberculosis therapy New England Journal of Medicine 362(22): 2138; Author Reply 2138-2139Tweya, H.; Ben-Smith, A.; Kalulu, M.; Jahn, A.; Ng'ambi, W.; Mkandawire, E.; Gabriel, L.; Phiri, S. 2014: Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi Bmc Public Health 14: 183
Vijayan, T.; Semitala, F.C.; Matsiko, N.; Elyanu, P.; Namusobya, J.; Havlir, D.V.; Kamya, M.; Geng, E.H. 2013: Changes in the timing of antiretroviral therapy initiation in HIV-infected patients with tuberculosis in Uganda: a study of the diffusion of evidence into practice in the global response to HIV/AIDS Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 57(12): 1766-1772
Muhamadi, L.; Nsabagasani, X.; Tumwesigye, M.Nazarius.; Wabwire-Mangen, F.; Ekström, A-Mia.; Peterson, S.; Pariyo, G. 2010: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda Health Policy 97(2-3): 187-194
Diouf, A.; Youbong, T.J.; Maynart, M.; Ndoye, M.; Diéye, F.L.; Ndiaye, N.A.; Koita-Fall, M.B.; Ndiaye, B.; Seydi, M. 2017: Non-antiretroviral drugs uses among HIV-infected persons receiving antiretroviral therapy in Senegal: Costs and factors associated with prescription Revue d'Epidemiologie et de Sante Publique 65(4): 295-300
Sungkanuparph, S.; Eampokalap, B.; Chottanapund, S.; Bed, S.Thongyen.; Manosuthi, W. 2007: Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy Journal of the Medical Association of Thailand 90(5): 884-888
Mankhatitham, W.; Lueangniyomkul, A.; Manosuthi, W. 2011: Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen Southeast Asian Journal of Tropical Medicine and Public Health 42(3): 651-658
Iurin, O.G. 2007: Indications for initiation of antiretroviral therapy in patients with HIV infection. Choice of first-line drugs and schemes of therapy Terapevticheskii Arkhiv 79(11): 67-69
Naidoo, K.; Baxter, C.; Abdool Karim, S.S. 2013: When to start antiretroviral therapy during tuberculosis treatment? Current Opinion in Infectious Diseases 26(1): 35-42
Patel, M.R.; Nana, M.; Yotebieng, M.; Tabala, M.; Behets, F.; Van Rie, A. 2014: Delayed antiretroviral therapy despite integrated treatment for tuberculosis and HIV infection International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 18(6): 694-699
Duval, X.; Trad, S.; Le Moing, V.; Longuet, P.; Leport, C.; Vildé, J.L. 2001: Paradoxical aggravation of tuberculosis after antiretroviral therapy in HIV-infected patients Presse Medicale 30(5): 213-216
Kanyerere, H.; Harries, A.D.; Tayler-Smith, K.; Jahn, A.; Zachariah, R.; Chimbwandira, F.M.; Mpunga, J. 2016: The rise and fall of tuberculosis in Malawi: associations with HIV infection and antiretroviral therapy Tropical Medicine and International Health: Tm and Ih 21(1): 101-107
Reid, S.E.; Reid, C.A.; Vermund, S.H. 2004: Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy International Journal of Std and Aids 15(11): 713-716
Shepherd, B.E.; Jenkins, C.A.; Parrish, D.D.; Glass, T.R.; Cescon, A.; Masabeu, A.; Chene, G.; de Wolf, F.; Crane, H.M.; Jarrin, I.; Gill, J.; del Amo, J.; Abgrall, S.; Khaykin, P.; Lehmann, C.; Ingle, S.M.; May, M.T.; Sterne, J.A.C.; Sterling, T.R.; Brodt, H.-R.; Casabona, J.; Cavassini, M.; Chêne, G.èv.; Costagliola, D.; Dabis, F.ço.; Monforte, A.D.'A.; del Amo, J.; de Wolf, F.; Fätkenheuer, G.; Gill, J.; Guest, J.; Haerry, D.H.-U.; Hogg, R.; Justice, A.; Mocroft, A.; Kitahata, M.; Lampe, F.; Reiss, P.; Saag, M.; Sterling, T.; Williams, M.; Zangerle, R.; Sterne, J.; May, M.; Ingle, S. 2013: Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis Aids 27(8): 1321-1329
Miyano, S.; Dube, C.; Kayama, N.; Ishikawa, N.; Nozaki, I.; Syakantu, G. 2013: Association between tuberculosis treatment outcomes and the mobile antiretroviral therapy programme in Zambia international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 17(4): 540-545
Sunpath, H.; Edwin, C.; Chelin, N.; Nadesan, S.; Maharaj, R.; Moosa, Y.; Smeaton, L.; Court, R.; Knight, S.; Gwyther, E.; Murphy, R.A. 2012: Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 16(7): 917-923
Auld, A.F.; Mbofana, F.; Shiraishi, R.W.; Alfredo, C.; Sanchez, M.; Ellerbrock, T.V.; Nelson, L.J. 2013: Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008 PloS one 8(1): e54665
Walters, E.; Duvenhage, J.; Draper, H.R.; Hesseling, A.C.; Van Wyk, S.S.; Cotton, M.F.; Rabie, H. 2014: Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age Archives of disease in childhood 99(11): 998-1003
Van Oosterhout, J.J.G.; Kumwenda, J.J.; Beadsworth, M.; Mateyu, G.; Longwe, T.; Burger, D.M.; Zijlstra, E.E. 2007: Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians Antiviral Therapy 12(4): 515-521
Taniguchi, H.; Izumi, S. 2007: A case of tuberculosis showing immune reconstitution syndrome after the initiation of antiretroviral therapy for HIV infection Kekkaku: 82(1): 27-31